Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiano Filetti

Showing results (91-100 of 154) with videos related to

Pageof 16
Sort By:
Biomaterials|May 20, 2014
Targeting the thyroid gland with thyroid-stimulating hormone (TSH)-nanoliposomesDonatella Paolino, Donato Cosco, Marco Gaspari, et al.
Journal of Molecular Endocrinology|December 20, 2013
Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigeneticsMaria D'Agostino, Marialuisa Sponziello, Cinzia Puppin, et al.
Journal of Cellular Physiology|June 3, 2006
Nucleotide receptors stimulation by extracellular ATP controls Hsp90 expression through APE1/Ref-1 in thyroid cancer cells: a novel tumorigenic pathwayAlex Pines, Nicoletta Bivi, Carlo Vascotto, et al.
Molecular Oncology|June 22, 2026
The role of miR-335-5p in the redifferentiation of BRAF p.V600E thyroid cancersValeria Pecce, Simone Bini, Marialuisa Sponziello, et al.
The Journal of Clinical Endocrinology and Metabolism|December 30, 2004
Regulation of iodide uptake and sodium/iodide symporter expression in the mcf-7 human breast cancer cell lineFranco Arturi, Elisabetta Ferretti, Ivan Presta, et al.
Urology|December 9, 2009
Expression of the sodium/iodide symporter in human prostate adenocarcinomaMichele Navarra, Salvatore Micali, Saverio M Lepore, et al.
The Journal of Clinical Endocrinology and Metabolism|April 5, 2002
Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804Francesca Lombardo, Eric Baudin, Eusebio Chiefari, et al.
Cancers|July 18, 2020
Loss of Function SETD2 Mutations in Poorly Differentiated Metastases from Two Hürthle Cell Carcinomas of the ThyroidValeria Pecce, Antonella Verrienti, Luana Abballe, et al.
Endocrine|July 21, 2012
Increased expression of pro-angiogenic factors and vascularization in thyroid hyperfunctioning adenomas with and without TSH receptor activating mutationsMarilena Celano, Marialuisa Sponziello, Giovanni Tallini, et al.
Surgery|December 5, 2009
Distinct loci on chromosome 1q21 and 6q22 predispose to familial nonmedullary thyroid cancer: a SNP array-based linkage analysis of 38 familiesInsoo Suh, Sebastiano Filetti, Menno R Vriens, et al.
Pageof 16

Showing results (91-100 of 154) with videos related to

Sort By:
Pageof 16
Biomaterials|May 20, 2014
Targeting the thyroid gland with thyroid-stimulating hormone (TSH)-nanoliposomesDonatella Paolino, Donato Cosco, Marco Gaspari, et al.
Journal of Molecular Endocrinology|December 20, 2013
Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigeneticsMaria D'Agostino, Marialuisa Sponziello, Cinzia Puppin, et al.
Journal of Cellular Physiology|June 3, 2006
Nucleotide receptors stimulation by extracellular ATP controls Hsp90 expression through APE1/Ref-1 in thyroid cancer cells: a novel tumorigenic pathwayAlex Pines, Nicoletta Bivi, Carlo Vascotto, et al.
Molecular Oncology|June 22, 2026
The role of miR-335-5p in the redifferentiation of BRAF p.V600E thyroid cancersValeria Pecce, Simone Bini, Marialuisa Sponziello, et al.
The Journal of Clinical Endocrinology and Metabolism|December 30, 2004
Regulation of iodide uptake and sodium/iodide symporter expression in the mcf-7 human breast cancer cell lineFranco Arturi, Elisabetta Ferretti, Ivan Presta, et al.
Urology|December 9, 2009
Expression of the sodium/iodide symporter in human prostate adenocarcinomaMichele Navarra, Salvatore Micali, Saverio M Lepore, et al.
The Journal of Clinical Endocrinology and Metabolism|April 5, 2002
Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804Francesca Lombardo, Eric Baudin, Eusebio Chiefari, et al.
Cancers|July 18, 2020
Loss of Function SETD2 Mutations in Poorly Differentiated Metastases from Two Hürthle Cell Carcinomas of the ThyroidValeria Pecce, Antonella Verrienti, Luana Abballe, et al.
Endocrine|July 21, 2012
Increased expression of pro-angiogenic factors and vascularization in thyroid hyperfunctioning adenomas with and without TSH receptor activating mutationsMarilena Celano, Marialuisa Sponziello, Giovanni Tallini, et al.
Surgery|December 5, 2009
Distinct loci on chromosome 1q21 and 6q22 predispose to familial nonmedullary thyroid cancer: a SNP array-based linkage analysis of 38 familiesInsoo Suh, Sebastiano Filetti, Menno R Vriens, et al.
Pageof 16